Avivomed
Roseville, US · Founded 2021 · Delaware corporation · 3 known investors
Find your way into Avivomed
48 people in our graph share verified history with the Avivomed team — schools, employers, funds. One of them is your warm intro.
Mudit K. Jainunlockedknows Paul Mazanec · together at Avivomed, Inc. (overlapped)
×3knows the team · via Avivomed, Inc.
knows the team · via University of St. Thomas
knows the team · via Envoy Medical Corporation
×6knows the team · via LSI / Agere Systems
Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea. Based in the Minneapolis area, it targets mild-to-moderate OSA patients who cannot tolerate CPAP.
Founders & leadership
Avivomed was founded in 2021 by Lynn Elliott and Mudit Jain.
LE
Lynn ElliottCo-Founder
MJ
Mudit JainCo-Founder
PM
Paul MazanecinChief Executive OfficerPaul Mazanec is an engineer with experience in product development and technical leadership at companies designing active implantable medical devices and consumer electronics. He is CEO of Avivomed, which develops minimally invasive neuromodulation therapies for obstructive sleep apnea.
SM
Stephen MassonNamed on SEC filing
Board
TC
Theresa C. PappasBoard director
KP
CD
Casper de ClercqBoard director
DR
Investors · 3
Reported raises · per SEC filings
Form D private placements$25.1M disclosed across 2 rounds · 2021–2026
▶$5MraisedApr 2026 · 7 investors · BiotechnologyRule 506(b)
▶$5MraisedApr 2026 · 7 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Paul MazanecExecutive Officer, Director
- Theresa C. PappasDirector
- Ketan PatelDirector
- Casper de ClercqDirector
- Douglas ReedDirector
- Mudit K. JainDirector
- Offering amount
- $12M
- Amount sold
- $5M
- First sale
- Apr 2026
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$20.1MraisedNov 2021 · 6 investors · BiotechnologyRule 506(b)
▶$20.1MraisedNov 2021 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ketan PatelDirector
- Mudit K. JainDirector
- Stephen MassonExecutive Officer, Director
- Casper de ClercqDirector
- Theresa C. PappasDirector
- Douglas ReedDirector
- Offering amount
- $32M
- Amount sold
- $20.1M
- First sale
- Nov 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapAVIA4 shared keywordsAVIA operates a network and advisory platform for health systems, providing benchmarking, market intelligence, and peer collaboration to support their digital transformation and AI adoption. It serves hospitals and health systems and includes offerings like AVIA Marketplace and Panda Health for evaluating digital health companies.
Iveacare4 shared keywordsIVEAcare develops neuromodulation and bioelectronics therapies, implantable medical devices aimed at treating chronic conditions for large patient populations. The company partners with physicians to advance new therapies in the treatment of unmet clinical needs.
Nuvomed3 shared keywordsNuvomed is a family-operated company that develops and distributes affordable health and wellness devices, with a focus on hearing enhancement, physical therapy, and mental wellness. It sells holistically therapeutic products to consumers across the United States, originally supplying small pharmacies.
Iriva Medical3 shared keywordsiRiva Medical is a development-stage medical device company building neuromodulation technology platforms to treat patients with chronic diseases. A NuXcel spinoff based in Minneapolis, it develops implantable neuromodulation therapies targeting large patient populations with unmet clinical needs.
Avvio Medical3 shared keywordsAvvio AMEA develops kidney stone treatment technology for urological care, targeting patients and healthcare providers across Asia, the Middle East, and Africa. It is the regional arm of Avvio Medical, whose investigational medical device has not yet received regulatory clearance.
Companies competing with Avivomed for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Avivomed do?
- Avivomed is a medical device company developing minimally invasive neuromodulation therapies for patients with obstructive sleep apnea. Based in the Minneapolis area, it targets mild-to-moderate OSA patients who cannot tolerate CPAP.
- Who founded Avivomed?
- Avivomed was founded by Lynn Elliott, Mudit Jain in 2021.
- Who are Avivomed's investors?
- Avivomed's investors include Hatteras Venture Partners, Treo Ventures, Llc, F-Prime Capital.
- How much funding has Avivomed raised?
- Avivomed has disclosed $25.1M raised across 2 rounds.
- Where is Avivomed headquartered?
- Avivomed is headquartered in Roseville, US.